Literature DB >> 31307975

α4β1 integrin associates with VEGFR2 in CLL cells and contributes to VEGF binding and intracellular signaling.

Alejandra Gutiérrez-González1, Noemí Aguilera-Montilla1, Estefanía Ugarte-Berzal2, Elvira Bailón1, Isabel Cerro-Pardo1, Clara Sánchez-Maroto1, Lara García-Campillo1, José A García-Marco3, Angeles García-Pardo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31307975      PMCID： PMC6650728          DOI： 10.1182/bloodadvances.2019000019

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  25 in total

1.  A mechanism for modulation of cellular responses to VEGF: activation of the integrins.

Authors:  T V Byzova; C K Goldman; N Pampori; K A Thomas; A Bett; S J Shattil; E F Plow
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

2.  Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.

Authors:  Maria Teresa de la Fuente; Benito Casanova; José V Moyano; Mercedes Garcia-Gila; Laura Sanz; José Garcia-Marco; Augusto Silva; Angeles Garcia-Pardo
Journal:  J Leukoc Biol       Date:  2002-03       Impact factor: 4.962

Review 3.  Angiogenic factors in chronic lymphocytic leukemia.

Authors:  Yi Xia; Rui-Nan Lu; Jianyong Li
Journal:  Leuk Res       Date:  2012-06-22       Impact factor: 3.156

4.  CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium.

Authors:  Kathleen J Till; David G Spiller; Robert J Harris; Haijuan Chen; Mirko Zuzel; John C Cawley
Journal:  Blood       Date:  2005-02-24       Impact factor: 22.113

Review 5.  The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia.

Authors:  Tait D Shanafelt; Neil E Kay
Journal:  Semin Oncol       Date:  2006-04       Impact factor: 4.929

6.  Highly purified CD38+ and CD38- sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin.

Authors:  C Pepper; R Ward; T T Lin; P Brennan; J Starczynski; M Musson; C Rowntree; P Bentley; K Mills; G Pratt; C Fegan
Journal:  Leukemia       Date:  2007-02-08       Impact factor: 11.528

7.  Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors.

Authors:  Hui Jin; Jingmei Su; Barbara Garmy-Susini; Jeanine Kleeman; Judy Varner
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

Review 8.  Integrin function in vascular biology: a view from 2013.

Authors:  Edward F Plow; Julia Meller; Tatiana V Byzova
Journal:  Curr Opin Hematol       Date:  2014-05       Impact factor: 3.284

9.  Alpha4beta1 integrin mediates selective endothelial cell responses to thrombospondins 1 and 2 in vitro and modulates angiogenesis in vivo.

Authors:  Maria J Calzada; Longen Zhou; John M Sipes; Jane Zhang; Henry C Krutzsch; M Luisa Iruela-Arispe; Douglas S Annis; Deane F Mosher; David D Roberts
Journal:  Circ Res       Date:  2003-12-29       Impact factor: 17.367

Review 10.  Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia.

Authors:  Michele Dal Bo; Erika Tissino; Dania Benedetti; Chiara Caldana; Riccardo Bomben; Giovanni Del Poeta; Gianluca Gaidano; Francesca Maria Rossi; Pietro Bulian; Antonella Zucchetto; Valter Gattei
Journal:  Curr Cancer Drug Targets       Date:  2016       Impact factor: 3.428
View more
  4 in total

1.  Growth Factors VEGF-A165 and FGF-2 as Multifunctional Biomolecules Governing Cell Adhesion and Proliferation.

Authors:  Antonín Sedlář; Martina Trávníčková; Roman Matějka; Šimon Pražák; Zuzana Mészáros; Pavla Bojarová; Lucie Bačáková; Vladimír Křen; Kristýna Slámová
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

2.  TKI-Resistant Renal Cancer Secretes Low-Level Exosomal miR-549a to Induce Vascular Permeability and Angiogenesis to Promote Tumor Metastasis.

Authors:  Zuodong Xuan; Chen Chen; Wenbin Tang; Shaopei Ye; Jianzhong Zheng; Yue Zhao; Zhiyuan Shi; Lei Zhang; Huimin Sun; Chen Shao
Journal:  Front Cell Dev Biol       Date:  2021-06-10

3.  Elements of the Endomucin Extracellular Domain Essential for VEGF-Induced VEGFR2 Activity.

Authors:  Zhengping Hu; Issahy Cano; Kahira L Saez-Torres; Michelle E LeBlanc; Magali Saint-Geniez; Yin-Shan Ng; Pablo Argüeso; Patricia A D'Amore
Journal:  Cells       Date:  2020-06-05       Impact factor: 6.600

Review 4.  Comparative Approach to the Temporo-Spatial Organization of the Tumor Microenvironment.

Authors:  Kendall L Langsten; Jong Hyuk Kim; Aaron L Sarver; Mark Dewhirst; Jaime F Modiano
Journal:  Front Oncol       Date:  2019-11-07       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.